Global Radioactive Monoclonal Antibody Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Radioactive Monoclonal Antibody Market Overview

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody

1.2 Radioactive Monoclonal Antibody Segment by Type

1.2.1 Global Radioactive Monoclonal Antibody Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Type 1

1.2.3 The Market Profile of Type 2

1.2.4 The Market Profile of Type 3

1.3 Global Radioactive Monoclonal Antibody Segment by Application

1.3.1 Radioactive Monoclonal Antibody Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Application 1

1.3.3 The Market Profile of Application 2

1.3.4 The Market Profile of Application 3

1.4 Global Radioactive Monoclonal Antibody Market by Region (2014-2026)

1.4.1 Global Radioactive Monoclonal Antibody Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3 Europe Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.1 Germany Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.2 UK Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.3 France Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.4 Italy Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.5 Spain Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.6 Russia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.3.7 Poland Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.4 China Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.5 Japan Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.6 India Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.8 Central and South America Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Radioactive Monoclonal Antibody Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Radioactive Monoclonal Antibody (2014-2026)

1.5.1 Global Radioactive Monoclonal Antibody Revenue Status and Outlook (2014-2026)

1.5.2 Global Radioactive Monoclonal Antibody Production Status and Outlook (2014-2026)

2 Global Radioactive Monoclonal Antibody Market Landscape by Player

2.1 Global Radioactive Monoclonal Antibody Production and Share by Player (2014-2019)

2.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Player (2014-2019)

2.3 Global Radioactive Monoclonal Antibody Average Price by Player (2014-2019)

2.4 Radioactive Monoclonal Antibody Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Radioactive Monoclonal Antibody Market Competitive Situation and Trends

2.5.1 Radioactive Monoclonal Antibody Market Concentration Rate

2.5.2 Radioactive Monoclonal Antibody Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Sanofi-Aventis SA (France)

3.1.1 Sanofi-Aventis SA (France) Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.1.3 Sanofi-Aventis SA (France) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.1.4 Sanofi-Aventis SA (France) Business Overview

3.2 Paladin Labs Inc. (Canada)

3.2.1 Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.2.3 Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.2.4 Paladin Labs Inc. (Canada) Business Overview

3.3 Novartis AG (Switzerland)

3.3.1 Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.3.3 Novartis AG (Switzerland) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.3.4 Novartis AG (Switzerland) Business Overview

3.4 Abbott Laboratories (USA)

3.4.1 Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.4.3 Abbott Laboratories (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.4.4 Abbott Laboratories (USA) Business Overview

3.5 Immunomedics, Inc. (USA)

3.5.1 Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.5.3 Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.5.4 Immunomedics, Inc. (USA) Business Overview

3.6 ALZA Corporation (USA)

3.6.1 ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.6.3 ALZA Corporation (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.6.4 ALZA Corporation (USA) Business Overview

3.7 OSI Pharmaceuticals, Inc. (USA)

3.7.1 OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.7.3 OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.7.4 OSI Pharmaceuticals, Inc. (USA) Business Overview

3.8 Progenics Pharmaceuticals, Inc. (USA)

3.8.1 Progenics Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.8.3 Progenics Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.8.4 Progenics Pharmaceuticals, Inc. (USA) Business Overview

3.9 F. Hoffmann-La Roche Ltd. (Switzerland)

3.9.1 F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.9.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

3.10 Cell Genesys Inc. (USA)

3.10.1 Cell Genesys Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.10.3 Cell Genesys Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.10.4 Cell Genesys Inc. (USA) Business Overview

3.11 GlaxoSmithKline Plc (UK)

3.11.1 GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.11.3 GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.11.4 GlaxoSmithKline Plc (UK) Business Overview

3.12 Spectrum Pharmaceuticals, Inc. (USA)

3.12.1 Spectrum Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.12.3 Spectrum Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.12.4 Spectrum Pharmaceuticals, Inc. (USA) Business Overview

3.13 Genentech Inc. (USA)

3.13.1 Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.13.3 Genentech Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.13.4 Genentech Inc. (USA) Business Overview

3.14 AstraZeneca PLC (UK)

3.14.1 AstraZeneca PLC (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.14.3 AstraZeneca PLC (UK) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.14.4 AstraZeneca PLC (UK) Business Overview

3.15 Pfizer Inc. (USA)

3.15.1 Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.15.3 Pfizer Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.15.4 Pfizer Inc. (USA) Business Overview

3.16 Amgen Inc. (USA)

3.16.1 Amgen Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.16.3 Amgen Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.16.4 Amgen Inc. (USA) Business Overview

3.17 Takeda Pharmaceutical Company Limited (Japan)

3.17.1 Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.17.3 Takeda Pharmaceutical Company Limited (Japan) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.17.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview

3.18 Medimmune, LLC (USA)

3.18.1 Medimmune, LLC (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.18.3 Medimmune, LLC (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.18.4 Medimmune, LLC (USA) Business Overview

3.19 Bristol-Myers Squibb Company (USA)

3.19.1 Bristol-Myers Squibb Company (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.19.3 Bristol-Myers Squibb Company (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.19.4 Bristol-Myers Squibb Company (USA) Business Overview

3.20 Dendreon Corporation (USA)

3.20.1 Dendreon Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.20.3 Dendreon Corporation (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.20.4 Dendreon Corporation (USA) Business Overview

3.21 Indevus Pharmaceuticals Inc. (USA)

3.21.1 Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.21.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.21.3 Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.21.4 Indevus Pharmaceuticals Inc. (USA) Business Overview

3.22 EUSA Pharma, (USA) Inc. (USA)

3.22.1 EUSA Pharma, (USA) Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.22.2 Radioactive Monoclonal Antibody Product Profiles, Application and Specification

3.22.3 EUSA Pharma, (USA) Inc. (USA) Radioactive Monoclonal Antibody Market Performance (2014-2019)

3.22.4 EUSA Pharma, (USA) Inc. (USA) Business Overview

4 Global Radioactive Monoclonal Antibody Production, Revenue (Value), Price Trend by Type

4.1 Global Radioactive Monoclonal Antibody Production and Market Share by Type (2014-2019)

4.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Type (2014-2019)

4.3 Global Radioactive Monoclonal Antibody Price by Type (2014-2019)

4.4 Global Radioactive Monoclonal Antibody Production Growth Rate by Type (2014-2019)

4.4.1 Global Radioactive Monoclonal Antibody Production Growth Rate of Type 1 (2014-2019)

4.4.2 Global Radioactive Monoclonal Antibody Production Growth Rate of Type 2 (2014-2019)

4.4.3 Global Radioactive Monoclonal Antibody Production Growth Rate of Type 3 (2014-2019)

5 Global Radioactive Monoclonal Antibody Market Analysis by Application

5.1 Global Radioactive Monoclonal Antibody Consumption and Market Share by Application (2014-2019)

5.2 Global Radioactive Monoclonal Antibody Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Radioactive Monoclonal Antibody Consumption Growth Rate of Application 1 (2014-2019)

5.2.2 Global Radioactive Monoclonal Antibody Consumption Growth Rate of Application 2 (2014-2019)

5.2.3 Global Radioactive Monoclonal Antibody Consumption Growth Rate of Application 3 (2014-2019)

6 Global Radioactive Monoclonal Antibody Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Radioactive Monoclonal Antibody Consumption by Region (2014-2019)

6.2 United States Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.3 Europe Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.4 China Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.5 Japan Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.6 India Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

7 Global Radioactive Monoclonal Antibody Production, Revenue (Value) by Region (2014-2019)

7.1 Global Radioactive Monoclonal Antibody Production and Market Share by Region (2014-2019)

7.2 Global Radioactive Monoclonal Antibody Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

8 Radioactive Monoclonal Antibody Manufacturing Analysis

8.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Radioactive Monoclonal Antibody Industrial Chain Analysis

9.2 Raw Materials Sources of Radioactive Monoclonal Antibody Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Radioactive Monoclonal Antibody

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Radioactive Monoclonal Antibody Market Forecast (2019-2026)

11.1 Global Radioactive Monoclonal Antibody Production, Revenue Forecast (2019-2026)

11.1.1 Global Radioactive Monoclonal Antibody Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Radioactive Monoclonal Antibody Price and Trend Forecast (2019-2026)

11.2 Global Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Radioactive Monoclonal Antibody Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Radioactive Monoclonal Antibody Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Radioactive Monoclonal Antibody Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Radioactive Monoclonal Antibody Product Picture

Table Global Radioactive Monoclonal Antibody Production and CAGR (%) Comparison by Type

Table Profile of Type 1

Table Profile of Type 2

Table Profile of Type 3

Table Radioactive Monoclonal Antibody Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Application 1

Table Profile of Application 2

Table Profile of Application 3

Figure Global Radioactive Monoclonal Antibody Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Germany Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure UK Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure France Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Italy Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Spain Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Russia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Poland Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure India Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Malaysia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Singapore Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Philippines Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Indonesia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Thailand Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Vietnam Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Central and South America Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Brazil Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Mexico Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Colombia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Turkey Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Egypt Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure South Africa Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Nigeria Radioactive Monoclonal Antibody Revenue and Growth Rate (2014-2026)

Figure Global Radioactive Monoclonal Antibody Production Status and Outlook (2014-2026)

Table Global Radioactive Monoclonal Antibody Production by Player (2014-2019)

Table Global Radioactive Monoclonal Antibody Production Share by Player (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Share by Player in 2018

Table Radioactive Monoclonal Antibody Revenue by Player (2014-2019)

Table Radioactive Monoclonal Antibody Revenue Market Share by Player (2014-2019)

Table Radioactive Monoclonal Antibody Price by Player (2014-2019)

Table Radioactive Monoclonal Antibody Manufacturing Base Distribution and Sales Area by Player

Table Radioactive Monoclonal Antibody Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Sanofi-Aventis SA (France) Profile

Table Sanofi-Aventis SA (France) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Paladin Labs Inc. (Canada) Profile

Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis AG (Switzerland) Profile

Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Abbott Laboratories (USA) Profile

Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Immunomedics, Inc. (USA) Profile

Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table ALZA Corporation (USA) Profile

Table ALZA Corporation (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table OSI Pharmaceuticals, Inc. (USA) Profile

Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Progenics Pharmaceuticals, Inc. (USA) Profile

Table Progenics Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile

Table F. Hoffmann-La Roche Ltd. (Switzerland) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Cell Genesys Inc. (USA) Profile

Table Cell Genesys Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Plc (UK) Profile

Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Spectrum Pharmaceuticals, Inc. (USA) Profile

Table Spectrum Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Genentech Inc. (USA) Profile

Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table AstraZeneca PLC (UK) Profile

Table AstraZeneca PLC (UK) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Inc. (USA) Profile

Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Amgen Inc. (USA) Profile

Table Amgen Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Takeda Pharmaceutical Company Limited (Japan) Profile

Table Takeda Pharmaceutical Company Limited (Japan) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Medimmune, LLC (USA) Profile

Table Medimmune, LLC (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Company (USA) Profile

Table Bristol-Myers Squibb Company (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Dendreon Corporation (USA) Profile

Table Dendreon Corporation (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Indevus Pharmaceuticals Inc. (USA) Profile

Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table EUSA Pharma, (USA) Inc. (USA) Profile

Table EUSA Pharma, (USA) Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Radioactive Monoclonal Antibody Production by Type (2014-2019)

Table Global Radioactive Monoclonal Antibody Production Market Share by Type (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Market Share by Type in 2018

Table Global Radioactive Monoclonal Antibody Revenue by Type (2014-2019)

Table Global Radioactive Monoclonal Antibody Revenue Market Share by Type (2014-2019)

Figure Global Radioactive Monoclonal Antibody Revenue Market Share by Type in 2018

Table Radioactive Monoclonal Antibody Price by Type (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Growth Rate of Type 1 (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Growth Rate of Type 2 (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Growth Rate of Type 3 (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption by Application (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption Market Share by Application (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption of Application 1 (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption of Application 2 (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption of Application 3 (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption by Region (2014-2019)

Table Global Radioactive Monoclonal Antibody Consumption Market Share by Region (2014-2019)

Table United States Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Europe Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table China Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Japan Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table India Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Central and South America Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Radioactive Monoclonal Antibody Production, Consumption, Export, Import (2014-2019)

Table Global Radioactive Monoclonal Antibody Production by Region (2014-2019)

Table Global Radioactive Monoclonal Antibody Production Market Share by Region (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Market Share by Region (2014-2019)

Figure Global Radioactive Monoclonal Antibody Production Market Share by Region in 2018

Table Global Radioactive Monoclonal Antibody Revenue by Region (2014-2019)

Table Global Radioactive Monoclonal Antibody Revenue Market Share by Region (2014-2019)

Figure Global Radioactive Monoclonal Antibody Revenue Market Share by Region (2014-2019)

Figure Global Radioactive Monoclonal Antibody Revenue Market Share by Region in 2018

Table Global Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table China Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table India Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Radioactive Monoclonal Antibody

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody

Figure Radioactive Monoclonal Antibody Industrial Chain Analysis

Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Players in 2018

Table Downstream Buyers

Figure Global Radioactive Monoclonal Antibody Production and Growth Rate Forecast (2019-2026)

Figure Global Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2019-2026)_